Lv3
204 积分 2025-02-28 加入
First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease
1个月前
已完结
Multi-target neuroprotection of Atractylodes macrocephala ethyl acetate extract against Alzheimer's disease: from bioactivity-guided screening to mechanistic validation
1个月前
已完结
Recent development in PDE4D-targeted inhibitors for Alzheimer's disease therapy
2个月前
已完结
组蛋白甲基化修饰在阿尔茨海默病中的作用及其中药干预研究进展
3个月前
已完结
Multi-target neuroprotection of Atractylodes macrocephala ethyl acetate extract against Alzheimer's disease: from bioactivity-guided screening to mechanistic validation
6个月前
已完结
Structural modification of atractylenolides: synthesis and evaluation of derivatives with potent anti-Aβ aggregation and neuroprotective activities against Alzheimer's disease
6个月前
已完结
Small molecule compounds targeting G9a/GLP: Recent advances and perspectives
6个月前
已完结
G9a/GLP Modulators: Inhibitors to Degraders
6个月前
已完结
浅谈中国公司智能手表专利及产品布局
7个月前
已完结
Upregulation of ISG15 induced by MAPT/tau accumulation represses autophagic flux by inhibiting HDAC6 activity: a vicious cycle in alzheimer disease
10个月前
已完结
皖公网安备34019202002308
